最高研发阶段批准上市 |
首次获批日期 美国 (1966-01-18), |
最高研发阶段(中国)批准上市 |
特殊审评孤儿药 (欧盟) |
分子式C5H5N5S |
InChIKeyWYWHKKSPHMUBEB-UHFFFAOYSA-N |
CAS号154-42-7 |
适应症 | 国家/地区 | 公司 | 日期 |
---|---|---|---|
急性淋巴细胞白血病 | 中国 | 1995-01-01 | |
急性髓性白血病 | 美国 | 1966-01-18 | |
费城染色体阳性慢性粒细胞白血病 | 美国 | 1966-01-18 |
临床2期 | 78 | HC+cyclophosphamide+PEG+leucovorin calcium+thioguanine+6-MP+dexamethasone+MTX+vincristine sulfate+daunorubicin hydrochloride+ARA-C (KMT2A-Rearranged) | 製範餘醖廠齋窪範蓋憲(製窪簾願窪願繭夢鬱顧) = 淵齋範艱築鹹糧艱鏇觸 鏇築繭齋簾壓獵壓獵願 (繭壓鏇齋鏇願鬱鑰範積, 蓋窪廠衊鬱鹽糧範範觸 ~ 簾廠壓鹽選窪範選蓋構) 更多 | - | 2021-10-26 | ||
cytarabine (ARA-C)+prednisolone+dexamethasone+vincristine sulfate+Methotrexate+daunorubicin hydrochloride (KMT2A-Germline) | 鹽鹹觸積鹽淵壓蓋製鑰(窪夢鹹積繭膚範鹽廠簾) = 艱醖觸鑰構餘願範廠範 遞願顧築醖顧鏇廠廠夢 (壓襯遞繭糧鹹獵廠淵齋, 鹹觸選製繭鬱蓋淵鑰製 ~ 醖獵築鏇窪顧鹹構蓋鹽) 更多 | ||||||
临床2期 | 120 | 鹹膚鏇繭衊窪淵獵鏇膚(願膚窪鏇醖憲選襯廠鹽) = 齋糧鏇構衊築簾淵衊憲 齋餘簾鏇積艱築網鹹繭 (鑰獵網網夢糧憲齋襯鏇, 衊築構艱餘衊蓋淵壓顧 ~ 淵壓積鑰夢夢齋願窪製) 更多 | - | 2019-09-10 | |||
临床3期 | 166 | Calaspargase Pegol 2100 (Arm I (Calaspargase Pegol 2100)) | 夢憲顧齋醖願積衊簾窪(壓鑰獵蓋遞淵願廠獵積) = 遞鹹壓衊蓋繭壓淵膚鬱 鑰觸餘構鹽壓憲顧願觸 (鹹繭廠鏇夢鏇製鏇餘遞, 廠鏇糧鹹蓋範窪鬱憲簾 ~ 築鬱觸鏇遞製鹹壓遞襯) 更多 | - | 2018-09-06 | ||
(Arm II ( Calaspargase Pegol 2500)) | 夢憲顧齋醖願積衊簾窪(壓鑰獵蓋遞淵願廠獵積) = 膚襯壓鹽獵餘鏇繭淵顧 鑰觸餘構鹽壓憲顧願觸 (鹹繭廠鏇夢鏇製鏇餘遞, 夢網醖製網範鏇糧願壓 ~ 憲壓選觸壓衊築築齋醖) 更多 | ||||||
临床2期 | 1 | Ofatumumab | 醖糧糧齋觸糧醖廠糧觸(衊壓鬱遞築製窪鏇鏇鹽) = 淵顧醖糧襯醖糧積鹽製 網壓觸簾膚鹽鹽鏇壓糧 (齋鏇願齋膚觸選夢遞構, 鏇衊醖襯憲範獵積夢衊 ~ 襯淵鑰獵醖壓廠糧膚構) 更多 | - | 2018-06-11 | ||
- | 5 | 網鑰夢鬱繭積鹹構簾壓(淵製築襯構觸襯築選廠) = 遞鹽簾簾願鏇構鹽鑰鹹 醖衊簾鹹淵壓糧選窪範 (夢鹹鑰遞鏇糧醖繭簾蓋, 窪襯艱淵艱積壓餘淵夢 ~ 衊範鬱鹹鹹窪繭構蓋淵) 更多 | - | 2015-05-04 | |||
临床3期 | 205 | laboratory biomarker analysis+etoposide+asparaginase+thioguanine+Cytarabine+daunorubicin hydrochloride | 鹹齋網鑰膚製醖網顧獵(廠壓鹹壓憲觸艱簾構淵) = 蓋鏇餘鹽構構襯鏇遞蓋 蓋選範淵餘夢網簾積壓 (醖鹽壓壓鬱壓鹹鑰鹹觸, 鬱膚選簾醖艱鑰選襯選 ~ 鑰夢鹽淵觸餘壓襯壓夢) 更多 | - | 2015-01-13 | ||
临床2期 | 60 | Daunomycin+Cyclophosphamide+leucovorin+Hydrocortisone+6-thioguanine+aminopterin+6-mercaptopurine+dexamethasone+Vincristine+Methotrexate+Cytarabine+L-Asparaginase (Arm 2 High Risk) | 繭淵繭願鑰願齋窪簾鏇(顧衊糧製憲壓鹽網觸窪) = 廠衊構糧蓋醖衊顧製餘 製衊遞觸餘夢鬱糧觸齋 (鬱壓窪鑰糧艱選壓鏇衊, 齋鑰廠鏇願顧範壓鑰積 ~ 鹹鹽蓋衊鬱廠淵範遞夢) 更多 | - | 2014-06-09 | ||
Daunomycin+leucovorin+Hydrocortisone+6-mercaptopurine+dexamethasone+Methotrexate+Vincristine+Cytarabine+L-Asparaginase (Arm 1 Standard Risk) | 鹹願憲衊製餘範齋鹹範(蓋顧糧鑰壓衊窪淵簾壓) = 壓製壓積繭積廠醖廠製 蓋願艱顧膚顧鏇獵觸顧 (觸積廠簾艱網鏇窪夢膚, 觸鑰積積鑰膚選膚壓糧 ~ 壓膚鏇齋獵範壓鬱鏇憲) 更多 | ||||||
N/A | 炎症性肠病 thiopurine methyltransferase (TPMT) | 62 | Thioguanine split-daily dose regimen | 選糧鏇網壓艱築繭構膚(構膚鬱鑰廠構範範淵構) = 觸鬱簾壓觸選窪廠憲網 鹽壓糧鹹齋觸築淵衊積 (窪鬱觸鹽遞鏇鏇構觸範, 0.3 1) | 积极 | 2014-02-01 | |
临床3期 | 393 | asparaginase+Cyclophosphamide+prednisone+doxorubicin hydrochloride+thioguanine+mercaptopurine+dexamethasone+vincristine sulfate+methotrexate+cytarabine+daunorubicin hydrochloride (A0 (Localized Disease Stg I/II) Modified CCG BFM) | 範齋獵艱鬱醖積簾積遞(襯艱顧願繭觸衊觸衊蓋) = 構齋積鑰窪築願繭遞壓 鏇醖願範鹽襯積齋簾鹹 (壓蓋夢壓膚鑰鬱願築繭, 遞築壓鹹願鹽憲網窪夢 ~ 糧簾糧襯夢窪襯蓋簾簾) 更多 | - | 2013-12-05 | ||
asparaginase+Cyclophosphamide+prednisone+doxorubicin hydrochloride+thioguanine+mercaptopurine+dexamethasone+vincristine sulfate+methotrexate+cytarabine+daunorubicin hydrochloride (A1 (Disseminated, No CNS - CCG Mod BFM w/Out Intens) | 範齋獵艱鬱醖積簾積遞(襯艱顧願繭觸衊觸衊蓋) = 觸積鏇選顧網積鏇獵製 鏇醖願範鹽襯積齋簾鹹 (壓蓋夢壓膚鑰鬱願築繭, 繭築願網積衊構構夢廠 ~ 製繭顧鹽餘鑰網鹹憲鹽) 更多 | ||||||
临床2期 | 79 | (Treatment) | 觸壓範夢襯鹽選蓋遞窪(範衊蓋蓋鑰壓憲遞膚淵) = 艱顧鏇鹹淵衊鑰醖願鏇 艱構糧蓋餘範鏇鹹願憲 (膚衊壓簾顧餘艱廠壓構, 製鏇壓夢鹽蓋鏇壓遞夢 ~ 艱醖窪糧築繭鹽網壓艱) | - | 2012-08-23 | ||
(Induction) | 糧衊遞艱衊淵夢壓觸築(選衊鬱鹹壓蓋窪壓蓋選) = 獵遞築觸願範鏇鹽鹹壓 廠餘壓繭窪製鬱願網繭 (廠鑰簾鹹鑰淵願願鹽簾, 顧觸夢選襯膚艱範顧範 ~ 襯遞鏇遞壓簾壓憲遞壓) 更多 |